Publication: Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Tanuma, Junko, Kyu Ha Lee, Sebastien Haneuse, Shoko Matsumoto, Dung Thi Nguyen, Dung Thi Hoai Nguyen, Cuong Duy Do, Thuy Thanh Pham, Kinh Van Nguyen, and Shinichi Oka. 2016. “Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014.” PLoS ONE 11 (3): e0150781. doi:10.1371/journal.pone.0150781. http://dx.doi.org/10.1371/journal.pone.0150781.
Research Data
Abstract
Background: Although the prognosis for HIV-infected individuals has improved after antiretroviral therapy (ART) scale-up, limited data exist on the incidence of AIDS-defining opportunistic infections (ADIs) and mortality during ART in resource-limited settings. Methods: HIV-infected adults in two large hospitals in urban Hanoi were enrolled to the prospective cohort, from October 2007 through December 2013. Those who started ART less than one year before enrollment were assigned to the survival analysis. Data on ART history and ADIs were collected retrospectively at enrollment and followed-up prospectively until April 2014. Results: Of 2,070 cohort participants, 1,197 were eligible for analysis and provided 3,446 person-years (PYs) of being on ART. Overall, 161 ADIs episodes were noted at a median of 3.20 months after ART initiation (range 0.03–75.8) with an incidence 46.7/1,000 PYs (95% confidence interval [CI] 39.8–54.5). The most common ADI was tuberculosis with an incidence of 29.9/1,000 PYs. Mortality after ART initiation was 8.68/1,000 PYs and 45% (19/45) died of AIDS-related illnesses. Age over 50 years at ART initiation was significantly associated with shorter survival after controlling for baseline CD4 count, but neither having injection drug use (IDU) history nor previous ADIs were associated with poor survival. Semi-competing risks analysis in 951 patients without ADIs history prior to ART showed those who developed ADIs after starting ART were at higher risk of death in the first six months than after six months. Conclusion: ADIs were not rare in spite of being on effective ART. Age over 50 years, but not IDU history, was associated with shorter survival in the cohort. This study provides in-depth data on the prognosis of patients on ART in Vietnam during the first decade of ART scale-up.
Description
Other Available Sources
Keywords
People and Places, Demography, Death Rates, Biology and Life Sciences, Population Biology, Population Metrics, Immunology, Vaccination and Immunization, Antiviral Therapy, Antiretroviral Therapy, Medicine and Health Sciences, Public and Occupational Health, Preventive Medicine, Infectious Diseases, Opportunistic Infections, Bacterial Diseases, Tuberculosis, Tropical Diseases, Geographical Locations, Asia, Vietnam, Diagnostic Medicine, Prognosis, Medicine and health sciences, Diagnostic medicine, HIV diagnosis and management, Physiology, Immune Physiology, Antigens, Antigenic Variation, Immune System Proteins, Biochemistry, Proteins
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service